Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Peripheral Neuropathies: early-phase trial registry
2 of 4 indexed Peripheral Neuropathies trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #4,115 of 28,707 conditions by registered trial count.
4 US clinical trials · 2 currently recruiting · #4,115 of 28,707 conditions by registered trial count
Peripheral Neuropathies: 4 US clinical trials tracked, 2 recruiting.
Peripheral Neuropathies is the subject of 4 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is National Center for Complementary and Integrative Health (NCCIH), running 1 of these trials.
Enrollment posture brief
Registry condition peripheral-neuropathies
OPEN 2 | RECR 50% | LATE 0 | EARLY 1 | RANK #4115 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Abdominal Aortic Aneurysms (50% recruiting · 6 trials)
Peripheral Neuropathies lists 2 open slots (50% of 4 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Peripheral Neuropathies on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Peripheral Neuropathies is recruiting above its size-band peers.
2 of 4 indexed trials (50%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
4 total, page 1 of 1
Balance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems
RxFunction
NCT06959277
Feasibility Testing of a Tai Chi Program for Chemotherapy-Induced Peripheral Neuropathy Treatment (TCT)
Dana-Farber Cancer Institute
NCT06807294
Acupuncture/Moxibustion for Peripheral Neuropathy in HIV
National Center for Complementary and Integrative Health (NCCIH)
NCT00317291
1068GCC Evaluate Efficacy & Explore Mechanism of Acupuncture in Treating Bortezomib-induced Peripheral Neuropathy (BIPN) in Multiple Myeloma
University of Maryland, Baltimore
NCT01541644
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Peripheral Neuropathies records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Peripheral Neuropathies trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Peripheral Neuropathies page
4 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Peripheral Neuropathies trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- National Center for Complementary and Integrative Health (NCCIH) sponsors the most Peripheral Neuropathies trials on record, review their full trial history before evaluating a specific study. See National Center for Complementary and Integrative Health (NCCIH)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Peripheral Neuropathies condition card totals 4 registered trials; most-linked intervention Sham acupuncture/Placebo moxibustion; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.